Dian Diagnostics Group Co (SZSE:300244) Total Stockholders Equity : ¥7,498 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Total Stockholders Equity?

Dian Diagnostics Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥7,498 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Dian Diagnostics Group Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥11.96. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Dian Diagnostics Group Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.58.

Dian Diagnostics Group Co Total Stockholders Equity Historical Data

The historical data trend for Dian Diagnostics Group Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Total Stockholders Equity Chart

Dian Diagnostics Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

3,983.80

4,697.87

5,841.98

7,448.10

7,566.27

Dian Diagnostics Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															7,568.66	7,761.15	7,846.48	7,566.27	7,497.59

Dian Diagnostics Group Co (SZSE:300244) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Dian Diagnostics Group Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7497.593	-	0)	/	626.898
	=	11.96

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Dian Diagnostics Group Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1799.287	+	2556.435)	/	7497.593
	=	0.58

Dian Diagnostics Group Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dian Diagnostics Group Co (SZSE:300244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030

Website

http://www.dazd.cn

Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.

Executives

Chen Hai Bin	Director
Chen Shi Shi	Supervisors
Guo San Hui	Executives
Yao Shu Lie	Executives
Xu Min	Director
Wang Yan Xiao	Directors, executives
Chen Zuo Xiu	Directors, executives
Hu Yong	Director
Hu Miao Shen	Executives
Chen Xue Dong	Director
Jiang Tang	Directors, executives
Tao Jun	Securities Affairs Representative
Wu Zheng Xin	Executives
Cheng Xiu Li	Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines